サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1643511

予測毒性学における人工知能の世界市場

Artificial Intelligence in Predictive Toxicology

出版日
ページ情報
英文 206 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
予測毒性学における人工知能の世界市場
出版日: 2025年01月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 206 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

予測毒性学における人工知能の世界市場は2030年までに22億米ドルに達する見込み

2024年に5億880万米ドルと推定される予測毒性学における人工知能の世界市場は、2024～2030年の分析期間中に27.5%のCAGRで成長し、2030年には22億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである予測毒物学ソリューションにおけるAIは、CAGR 24.8%を記録し、分析期間終了までに14億米ドルに達すると予測されます。予測毒物学サービスにおけるAIセグメントの成長は、分析期間中CAGR 33.2%と推定されます。

米国市場は1億3,370万米ドルと推定、中国はCAGR26.2％で成長予測

米国の予測毒性学における人工知能市場は、2024年に1億3,370万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを26.2%として、2030年までに3億3,330万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、それぞれ分析期間中に24.7%と24.0%のCAGRで成長すると予測されています。欧州では、ドイツがCAGR約19.3%で成長すると予測されています。

世界の予測毒性学における人工知能市場- 主要動向と促進要因まとめ

AIは毒物検査にどのような革命をもたらすか？

人工知能（AI）は、化学物質や物質の毒性を予測するための、より速く、より正確で、費用対効果の高い方法を可能にすることで、毒性学に変革をもたらしつつあります。動物実験や長時間の実験手順に依存することが多い従来の毒性学的評価は、大規模なデータセットに基づいて人間の反応をシミュレートするAI搭載の予測モデルに取って代わられつつあります。AIは、機械学習（ML）、深層学習（DL）、データ解析を活用して分子構造を解析し、潜在的な毒性作用を高い精度で予測します。

予測毒性学におけるAIの主な用途の1つは、医薬品開発や化学物質製造の初期段階で有毒物質を特定する能力です。化学的特性、生物学的相互作用、実験結果から得られる膨大なデータセットを分析することで、AIシステムは有害である可能性の高い化合物を迅速に特定することができます。これにより開発プロセスが加速され、安全性試験にかかる時間とコストが大幅に削減されます。また、さまざまな生物学的系における毒性を予測するAIの能力は、動物実験への依存を減らし、倫理基準や規制基準に合致させる。

AIモデルはまた、発がん性、生殖毒性、神経毒性など、化学物質への暴露による長期的な影響を予測する能力を高める。これらの能力は、医薬品、化学物質、環境安全などの業界にとって極めて重要であり、有害物質を早期に特定することで人命を救い、規制違反を防ぐことができます。

予測毒性学におけるAIの採用を促進するものは何か？

安全性と規制遵守の重視の高まりは、予測毒性学におけるAI導入の重要な促進要因です。環境汚染、化学物質への曝露、動物実験の倫理的意味合いに対する世界の懸念が高まる中、AIは従来の毒物学的手法に代わる有望な選択肢を提供しています。AIシステムは、化学物質の安全性を評価するための、より信頼性が高く、スケーラブルで正確な方法を規制機関や業界に提供します。

さらに、精密医療と個別化医療の台頭は、毒性学における高度な予測ツールの必要性を加速させています。より個別化された医薬品が開発されるにつれ、特定の化合物がさまざまな遺伝子プロファイルにどのような影響を与えるかを理解することがますます重要になっています。複雑な生物学的データを分析し、個人の遺伝的構成に基づいて毒物学的影響を予測するAIの能力は、医薬品の安全性と有効性を高め、特定の患者グループに合わせた治療を保証します。

より効率的で持続可能な研究手法へのシフトも、予測毒性学におけるAIの採用を後押ししています。従来の毒性学的研究は時間とコストがかかるが、AIシステムはハイスループット・スクリーニングと迅速な毒性予測を可能にします。これにより、特に安全性試験が市場参入に不可欠な製薬、化学、消費財業界では、製品開発の全体的なコストが削減されます。

AIは毒性予測の精度と効率を改善できるか？

AIは毒性予測の精度と効率を大幅に向上させ、従来の方法の限界に対処しています。従来の毒性試験は、多くの場合、コストと時間のかかる大規模なin vivo試験を伴う。AIアルゴリズムは、化学的特性と生物学的結果の大規模なデータセットを分析することで、手作業よりもはるかに優れた精度とスピードで毒性を予測することができます。これらのAI駆動モデルは、何百万もの化合物を迅速に分析し、さらなる調査が必要な化合物に優先順位をつけることができます。

さらに、AIシステムは、代謝プロセスや遺伝的変異など、毒性に影響を与える複雑な変数を考慮することで、予測精度を向上させる。ゲノミクス、プロテオミクス、その他の分野のデータを統合することで、AIは毒性モデルの予測能力を高め、よりロバストで信頼性の高いものにします。これにより、潜在的な安全性懸念の早期発見が可能になり、より安全な化学物質や医薬品が市場に出回るようになります。

予測毒性学におけるAIのもう一つの大きな利点は、新しいデータから継続的に学習する能力です。より多くの毒性データが利用可能になると、機械学習アルゴリズムは予測を改良し、時間の経過とともに改善していく。この反復学習プロセスにより、AIシステムは精度の最先端を維持し、より優れたリスク評価を可能にし、化学物質や医薬品の安全性プロファイルを改善することができます。

予測毒性学分野におけるAI市場の成長を牽引しているのは？

予測毒性学における人工知能市場の成長は、より安全で効率的な検査方法に対する需要の高まりを反映した、いくつかの主要な要因によって牽引されています。医薬品や化学製品に対する世界の需要の高まりは、厳しい安全規制と相まって、高度な予測毒性学ツールの必要性を煽っています。AIはこうした需要に応える効率的でスケーラブルなソリューションを提供し、毒性試験に必要なコストと時間を大幅に削減します。

持続可能で倫理的な試験方法へのシフトの高まりも、AIの採用を後押ししています。動物実験の削減を求める社会的・規制的圧力が高まる中、AIを活用したモデルは、動物実験に伴う倫理的な懸念なしに化学物質の安全性を評価するための実行可能な代替手段を提供します。

ディープラーニング、ビッグデータ解析、高性能コンピューティングといったAIの技術的進歩は、毒物学モデルの予測能力を高めています。これらの技術革新により、AIシステムは様々なソースからの膨大なデータを処理できるようになり、毒性予測の精度が向上しています。

最後に、環境安全性におけるAIの統合と規制遵守の重要性の高まりが、複数の業界にわたるAI主導の予測毒性学ツールの採用を後押ししています。これらの要因は、AI研究への投資の増加と相まって、市場の急成長を後押しし、AIを毒性試験の将来における重要なプレーヤーとして確立しています。

セグメント

コンポーネント（ソリューション・コンポーネント、サービス・コンポーネント）、テクノロジー（機械学習テクノロジー、自然言語処理テクノロジー、コンピュータ・ビジョン・テクノロジー、その他テクノロジー）、毒性エンドポイント（遺伝子毒性エンドポイント、肝毒性エンドポイント、神経毒性エンドポイント、心毒性エンドポイント、その他毒性エンドポイント）、エンド用途（製薬・バイオテクノロジー企業エンド用途、化学・化粧品エンド用途、受託研究機関エンド用途、その他エンド用途）

調査対象企業の例（注目の36社）

  • AbbVie, Inc.
  • BenevolentAI
  • Biovista Inc.
  • ChemAxon
  • Exscientia Plc
  • Insilico Medicine
  • Instem Plc
  • Lhasa Limited
  • Recursion Pharmaceuticals

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP29264

Global Artificial Intelligence in Predictive Toxicology Market to Reach US$2.2 Billion by 2030

The global market for Artificial Intelligence in Predictive Toxicology estimated at US$508.8 Million in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 27.5% over the analysis period 2024-2030. AI in Predictive Toxicology Solutions, one of the segments analyzed in the report, is expected to record a 24.8% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the AI in Predictive Toxicology Services segment is estimated at 33.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$133.7 Million While China is Forecast to Grow at 26.2% CAGR

The Artificial Intelligence in Predictive Toxicology market in the U.S. is estimated at US$133.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$333.3 Million by the year 2030 trailing a CAGR of 26.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 24.7% and 24.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 19.3% CAGR.

Global Artificial Intelligence in Predictive Toxicology Market - Key Trends & Drivers Summarized

How Is AI Revolutionizing Toxicology Testing?

Artificial Intelligence (AI) is transforming toxicology by enabling faster, more accurate, and cost-effective methods for predicting the toxicity of chemicals and substances. Traditional toxicological assessments, which often rely on animal testing and lengthy experimental procedures, are being replaced by AI-powered predictive models that simulate human responses based on large datasets. AI leverages machine learning (ML), deep learning (DL), and data analytics to analyze molecular structures and predict potential toxic effects with high precision.

One of the key applications of AI in predictive toxicology is its ability to identify toxic substances at an early stage of drug development or chemical manufacturing. By analyzing vast datasets from chemical properties, biological interactions, and experimental results, AI systems can quickly identify compounds that are likely to be harmful. This accelerates the development process and significantly reduces the time and cost associated with safety testing. AI’s ability to predict toxicity in various biological systems also reduces the reliance on animal testing, aligning with ethical and regulatory standards.

AI models also enhance the ability to predict the long-term effects of exposure to chemicals, such as carcinogenicity, reproductive toxicity, and neurotoxicity. These capabilities are crucial for industries such as pharmaceuticals, chemicals, and environmental safety, where early identification of harmful substances can save lives and prevent regulatory violations.

What Drives the Adoption of AI in Predictive Toxicology?

The growing emphasis on safety and regulatory compliance is a significant driver of AI adoption in predictive toxicology. With increasing global concerns about environmental pollution, chemical exposure, and the ethical implications of animal testing, AI offers a promising alternative to traditional toxicology practices. AI systems provide regulatory bodies and industries with more reliable, scalable, and accurate methods for assessing chemical safety.

Additionally, the rise of precision medicine and personalized health care is accelerating the need for advanced predictive tools in toxicology. As more individualized drugs are developed, understanding how specific compounds affect different genetic profiles becomes increasingly important. AI’s ability to analyze complex biological data and predict toxicological effects based on an individual’s genetic makeup enhances drug safety and efficacy, ensuring that treatments are tailored to specific patient groups.

The shift toward more efficient and sustainable research practices is also driving the adoption of AI in predictive toxicology. Traditional toxicological studies can be time-consuming and expensive, while AI systems enable high-throughput screening and rapid toxicity predictions. This reduces the overall cost of product development, particularly in the pharmaceutical, chemical, and consumer goods industries, where safety testing is critical to market entry.

Can AI Improve the Accuracy and Efficiency of Toxicity Prediction?

AI is significantly improving the accuracy and efficiency of toxicity prediction, addressing the limitations of conventional methods. Traditional toxicology testing often involves extensive in vivo studies, which can be costly and time-consuming. AI algorithms, by analyzing large datasets of chemical properties and biological outcomes, can predict toxicity with a level of accuracy and speed that is far superior to manual methods. These AI-driven models can rapidly analyze millions of compounds, prioritizing those that need further investigation.

Furthermore, AI systems improve prediction accuracy by accounting for complex variables that influence toxicity, such as metabolic processes and genetic variations. By integrating data from genomics, proteomics, and other disciplines, AI enhances the predictive capabilities of toxicology models, making them more robust and reliable. This enables early-stage detection of potential safety concerns, leading to safer chemicals and drugs entering the market.

Another major advantage of AI in predictive toxicology is its ability to continuously learn from new data. As more toxicological data becomes available, machine learning algorithms refine their predictions, improving over time. This iterative learning process ensures that AI systems remain at the forefront of accuracy, enabling better risk assessments and improving safety profiles for chemicals and pharmaceuticals.

What’s Driving the Growth of the AI in Predictive Toxicology Market?

The growth in the Artificial Intelligence in Predictive Toxicology market is driven by several key factors, reflecting the increasing demand for safer and more efficient testing methods. The rising global demand for pharmaceutical and chemical products, coupled with stringent safety regulations, is fueling the need for advanced predictive toxicology tools. AI offers an efficient, scalable solution to meet these demands, significantly reducing the cost and time required for toxicity testing.

The growing shift toward sustainable and ethical testing methods is also propelling AI adoption. As public and regulatory pressure to reduce animal testing increases, AI-powered models offer a viable alternative for assessing chemical safety without the ethical concerns associated with animal studies.

Technological advancements in AI, such as deep learning, big data analytics, and high-performance computing, are enhancing the predictive capabilities of toxicology models. These innovations are enabling AI systems to process vast amounts of data from various sources, improving the accuracy of toxicity predictions.

Finally, the integration of AI in environmental safety and the growing importance of regulatory compliance are supporting the adoption of AI-driven predictive toxicology tools across multiple industries. These factors, combined with increasing investments in AI research, are fueling the rapid growth of the market and establishing AI as a key player in the future of toxicology testing.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence in Predictive Toxicology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Solutions Component, Services Component); Technology (Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology, Other Technologies); Toxicity Endpoint (Genotoxicity Endpoint, Hepatotoxicity Endpoint, Neurotoxicity Endpoint, Cardiotoxicity Endpoint, Other Toxicity Endpoints); End-Use (Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • AbbVie, Inc.
  • BenevolentAI
  • Biovista Inc.
  • ChemAxon
  • Exscientia Plc
  • Insilico Medicine
  • Instem Plc
  • Lhasa Limited
  • Recursion Pharmaceuticals

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Artificial Intelligence in Predictive Toxicology - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Preclinical Drug Testing Needs Drive Growth of AI-Driven Toxicity Prediction Models
    • Demand for AI in Reducing Animal Testing Strengthens Case for Ethical Toxicology Solutions
    • AI-Enhanced Toxicology Workflows Drive Market Demand in Drug Safety Assessment
    • Emerging AI Tools for Environmental Toxicology Highlight Market Potential
    • AI Models for Carcinogenicity Prediction Spur Growth in Chemical Risk Assessment
    • Advancements in AI for Neurotoxicity Screening Propel Innovation in CNS Drug Development
    • AI Solutions for Predictive Risk Assessment Sustain Growth in Consumer Product Testing
    • AI in Food Toxicology Highlights Opportunities for Safer Food Additives
    • AI-Driven Endocrine Disruptor Screening Strengthens Case for Safer Product Formulation
    • Integration of AI in Nanotoxicology Sets the Stage for Innovations in Material Safety
    • AI Tools for Dermal Toxicity Testing Propel Growth in Cosmetic Safety Markets
    • Growing Focus on AI in Reproductive Toxicity Studies Bodes Well for Regulatory Adherence
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence in Predictive Toxicology Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Solutions Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Solutions Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cardiotoxicity Endpoint by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Cardiotoxicity Endpoint by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Toxicity Endpoints by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Toxicity Endpoints by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Genotoxicity Endpoint by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Genotoxicity Endpoint by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hepatotoxicity Endpoint by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Hepatotoxicity Endpoint by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Neurotoxicity Endpoint by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Neurotoxicity Endpoint by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Chemical & Cosmetics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Chemical & Cosmetics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Contract Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Machine Learning Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Machine Learning Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Natural Language Processing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Natural Language Processing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Computer Vision Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Computer Vision Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • CANADA
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 58: China Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 76: France Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 100: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030

IV. COMPETITION